It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Yes-associated protein 1 (YAP) is a transcriptional regulator with critical roles in mechanotransduction, organ size control, and regeneration. Here, using advanced tools for real-time visualization of native YAP and target gene transcription dynamics, we show that a cycle of fast exodus of nuclear YAP to the cytoplasm followed by fast reentry to the nucleus (“localization-resets”) activates YAP target genes. These “resets” are induced by calcium signaling, modulation of actomyosin contractility, or mitosis. Using nascent-transcription reporter knock-ins of YAP target genes, we show a strict association between these resets and downstream transcription. Oncogenically-transformed cell lines lack localization-resets and instead show dramatically elevated rates of nucleocytoplasmic shuttling of YAP, suggesting an escape from compartmentalization-based control. The single-cell localization and transcription traces suggest that YAP activity is not a simple linear function of nuclear enrichment and point to a model of transcriptional activation based on nucleocytoplasmic exchange properties of YAP.
The transcriptional regulator YAP shuttles rapidly between the cytoplasm and nucleus, but whether and how dynamics such as amplitude and frequency affect target gene transcription is unclear. Here, using live imaging of endogenous YAP and target-gene transcription, the authors show that YAP-dependent signalling is encoded through rapid and concerted changes in the nucleo-cytoplasmic distribution of YAP.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Stanford University, Bioengineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, BioX Institute, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford Cancer Institute, Cell Biology Division, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, Chemical Engineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
2 Stanford University, Bioengineering, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, BioX Institute, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford University, ChEM-H, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956); Stanford Cancer Institute, Cell Biology Division, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)